Aurora Cannabis (ACB) Expected to Announce Quarterly Earnings on Wednesday

Aurora Cannabis (NASDAQ:ACB) is expected to post its Q4 2025 quarterly earnings results before the market opens on Wednesday, June 18th. Analysts expect the company to announce earnings of $0.11 per share and revenue of $88.85 million for the quarter.

Aurora Cannabis Stock Performance

Shares of Aurora Cannabis stock opened at $5.95 on Wednesday. The stock has a market cap of $334.47 million, a PE ratio of 119.02 and a beta of 1.82. Aurora Cannabis has a 12 month low of $3.42 and a 12 month high of $7.20. The company has a quick ratio of 1.60, a current ratio of 3.30 and a debt-to-equity ratio of 0.07. The business has a fifty day simple moving average of $4.84 and a 200-day simple moving average of $4.69.

Institutional Trading of Aurora Cannabis

An institutional investor recently raised its position in Aurora Cannabis stock. Goldman Sachs Group Inc. boosted its holdings in shares of Aurora Cannabis Inc. (NASDAQ:ACB) by 4.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 743,903 shares of the company’s stock after acquiring an additional 29,099 shares during the quarter. Goldman Sachs Group Inc. owned approximately 1.32% of Aurora Cannabis worth $3,266,000 at the end of the most recent reporting period. 47.63% of the stock is currently owned by hedge funds and other institutional investors.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.